Zobrazeno 1 - 10
of 358
pro vyhledávání: '"B Dubray"'
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Low skeletal muscle mass is a well-known prognostic factor for patients treated for a non-small-cell lung cancer by surgery or chemotherapy. However, its impact in patients treated by exclusive radiochemotherapy has never been explored. Our
Externí odkaz:
https://doaj.org/article/838097ce56c543438398c3f5fa881753
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 147:780-782
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annales de dermatologie et de venereologie. 147(11)
Autor:
Emmanuel Kammerer, Abdulhamid Chaikh, S. Thureau, J.M. Fontbonne, Juliette Thariat, T. Tessonnier, Jacques Balosso, B. Dubray, C. Fontbonne
Publikováno v:
Cancer/Radiothérapie
Cancer/Radiothérapie, 2020, 24 (3), pp.247-257. ⟨10.1016/j.canrad.2019.12.004⟩
Cancer/Radiothérapie, 2020, 24 (3), pp.247-257. ⟨10.1016/j.canrad.2019.12.004⟩
International audience; La prescription de la dose en radiothérapie est actuellement basée sur des abaques qui ne prennent pas en compte la complexité de la relation patient/dose/effet. Leurs performances prédictives tant sur l’efficacité anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc4635a78091a77fcd262b958928bca
https://hal.archives-ouvertes.fr/hal-02905908
https://hal.archives-ouvertes.fr/hal-02905908
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2019, 23, pp.904-912. ⟨10.1016/j.canrad.2019.08.006⟩
Cancer/Radiothérapie
Cancer/Radiothérapie, 2019, 23, pp.904-912. ⟨10.1016/j.canrad.2019.08.006⟩
Cancer Radiothérapie, Elsevier Masson, 2019, 23, pp.904-912. ⟨10.1016/j.canrad.2019.08.006⟩
Cancer/Radiothérapie
Cancer/Radiothérapie, 2019, 23, pp.904-912. ⟨10.1016/j.canrad.2019.08.006⟩
Adjuvant radiotherapy is a key treatment in early-stage breast cancer. The meta-analysis by the Early Breast Cancer Trialist's Collaborative Group (EBCTCG) has demonstrated a decreased risk of locoregional relapse and death after whole-breast radioth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90bf75776eed6d004741754f0a77ad5e
https://hal.archives-ouvertes.fr/hal-03488992
https://hal.archives-ouvertes.fr/hal-03488992
Publikováno v:
Radiotherapy and Oncology. 161:S1496
Autor:
A, Chaikh, J, Thariat, S, Thureau, T, Tessonnier, E, Kammerer, C, Fontbonne, B, Dubray, J, Balosso, J M, Fontbonne
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 24(3)
In radiotherapy, the dose prescription is currently based on discretized dose-effects records that do not take into fully account for the complexity of the patient-dose-response relationship. Their predictive performance on both anti-tumour efficacy
Publikováno v:
Molecular imaging and biology. 22(3)
The high rates of failure in the radiotherapy target volume suggest that patients with stage II or III non-small-cell lung cancer (NSCLC) should receive an increased total dose of radiotherapy. 2-Deoxy-2-[Thirty-four patients with non-resectable lung
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 23(8)
Adjuvant radiotherapy is a key treatment in early-stage breast cancer. The meta-analysis by the Early Breast Cancer Trialist's Collaborative Group (EBCTCG) has demonstrated a decreased risk of locoregional relapse and death after whole-breast radioth